Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
This study is currently recruiting participants.
Verified August 2012 by Endocyte
Sponsor:
Endocyte
Information provided by (Responsible Party):
Endocyte
ClinicalTrials.gov Identifier:
NCT01170650
First received: July 7, 2010
Last updated: August 7, 2012
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | May 2015 |
| Estimated Primary Completion Date: | June 2013 (Final data collection date for primary outcome measure) |